National Institutes of Health (NIH) Has A New $248 Million Focus: Electroceuticals

Published: Jul 07, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

When drugs can’t coax cells in the pancreas to produce insulin, or loosen arteries to reduce blood pressure, a well-placed jolt of electricity might do the trick. Spurred by decades of success with pacemakers and cochlear implants, and by advances in miniaturized technology, interest is surging in ‘electroceuticals’ — bioelectronic implants that stimulate nerves to treat disease.

Next week, the US National Institutes of Health (NIH) will announce a US$248-million effort to map the body’s electrical wiring and develop such devices. Pharmaceutical giant GlaxoSmithKline (GSK) has already set up a similar programme — and biotechnology companies are on the verge of bringing products to market.

Help employers find you! Check out all the jobs and post your resume.

Back to news